SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-23-006987
Filing Date
2023-03-08
Accepted
2023-03-08 16:18:58
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B3 vlon-424b3.htm 424B3 5148800
2 annexg1aa.jpg GRAPHIC 421687
3 descriptionofgri10aa.jpg GRAPHIC 187553
4 descriptionofgri11aa.jpg GRAPHIC 130686
5 descriptionofgri12aa.jpg GRAPHIC 84219
6 descriptionofgri13ba.jpg GRAPHIC 592987
7 descriptionofgri14aa.jpg GRAPHIC 329992
8 descriptionofgri15aa.jpg GRAPHIC 87953
9 descriptionofgri16aa.jpg GRAPHIC 102233
10 descriptionofgri1aa.jpg GRAPHIC 402256
11 descriptionofgri2aa.jpg GRAPHIC 595398
12 descriptionofgri3aa.jpg GRAPHIC 360229
13 descriptionofgri4aa.jpg GRAPHIC 72107
14 descriptionofgri5aa.jpg GRAPHIC 56379
15 descriptionofgri6aa.jpg GRAPHIC 142188
16 descriptionofgri7aa.jpg GRAPHIC 68579
17 descriptionofgri8aa.jpg GRAPHIC 50707
18 descriptionofgri9aa.jpg GRAPHIC 74701
  Complete submission text file 0001628280-23-006987.txt   10280743
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268977 | Film No.: 23716351
SIC: 2834 Pharmaceutical Preparations